Aminobenzoic acids and derivatives
Chemscene 2-Chloro-4-methylpyrimidine | 25g | CS-D1513 | 98% | 13036-57-2 | MFCD00054434 | 128 56 | C5H5ClN2
Chemscene | 2-Chloro-4-methylpyrimidine | 25g | CS-D1513 | 98% | 13036-57-2 | MFCD00054434 | 128 56 | C5H5ClN2
Apexbio Technology LLC Ac-Endothelin-1 (16-21), human 10mg
Ac-Endothelin-1 16-21 human is a selective agonist targeting the ETB subtype of G protein-coupled endothelin receptors It is designed to activate ETB receptors thereby modulating phospholipase C-mediated signaling pathways and vascular function Ac-Endothelin-1 16-21 human exerts its biological activity primarily through selective ETB receptor activation leading to vasoconstrictive effects Based on these pharmacological properties Ac-Endothelin-1 16-21 human holds research potential in studies analyzing vascular function as well as investigations of cardiovascular and renal pathophysiology
Chemscene 3-Phenylpyridine | 100g | CS-W016252 | 98% | 1008-88-4 | MFCD00006380 | 155 2 | C11H9N
Chemscene | 3-Phenylpyridine | 100g | CS-W016252 | 98% | 1008-88-4 | MFCD00006380 | 155 2 | C11H9N
Chemscene (4S 4 S)-2 2 -(Propane-2 2-diyl)bis(4-phenyl-4 5-dihydrooxazole) | 250mg | CS-W014499 | 98% | 131457-46-0 | MFCD00192245 | 334 42 | C21H22N2O2
Chemscene | (4S 4 S)-2 2 -(Propane-2 2-diyl)bis(4-phenyl-4 5-dihydrooxazole) | 250mg | CS-W014499 | 98% | 131457-46-0 | MFCD00192245 | 334 42 | C21H22N2O2
Chemscene Benzylideneacetone | 1kg | CS-W013311 | 98% | 122-57-6 | MFCD00008779 | 146 19 | C10H10O
Chemscene | Benzylideneacetone | 1kg | CS-W013311 | 98% | 122-57-6 | MFCD00008779 | 146 19 | C10H10O
Chemscene Ligustrazine | 25g | CS-W023183 | 98% | 1124-11-4 | MFCD00006146 | 136 20 | C8H12N2
Chemscene | Ligustrazine | 25g | CS-W023183 | 98% | 1124-11-4 | MFCD00006146 | 136 20 | C8H12N2
TARGETMOL CHEMICALS INC GS-9667 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 500 mg and bulk. Please contact Fisher for quotes. GS-9667 a selective and partial agonist of the A(1) adenosine receptor (AR) represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA). purity: 99%
Chemscene Boc-L-homophenylalanine | 5g | CS-D1787 | 98% | 100564-78-1 | MFCD00076904 | 279 34 | C15H21NO4
Chemscene | Boc-L-homophenylalanine | 5g | CS-D1787 | 98% | 100564-78-1 | MFCD00076904 | 279 34 | C15H21NO4
Chemscene (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-methionine | 100g | CS-W009765 | 98% | 112883-40-6 | MFCD00062958 | 371 45 | C20H21NO4S
Chemscene | (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-methionine | 100g | CS-W009765 | 98% | 112883-40-6 | MFCD00062958 | 371 45 | C20H21NO4S
Chemscene N N-Bis(4-phenylphenyl)amine | 25g | CS-W003501 | 98% | 102113-98-4 | MFCD08276279 | 321 42 | C24H19N
Chemscene | N N-Bis(4-phenylphenyl)amine | 25g | CS-W003501 | 98% | 102113-98-4 | MFCD08276279 | 321 42 | C24H19N
Chemscene Tri-p-tolylphosphine | 500g | CS-W012099 | 97% | 1038-95-5 | MFCD00008542 | 304 37 | C21H21P
Chemscene | Tri-p-tolylphosphine | 500g | CS-W012099 | 97% | 1038-95-5 | MFCD00008542 | 304 37 | C21H21P
Chemscene N N-Bis(4-phenylphenyl)amine | 100g | CS-W003501 | 98% | 102113-98-4 | MFCD08276279 | 321 42 | C24H19N
Chemscene | N N-Bis(4-phenylphenyl)amine | 100g | CS-W003501 | 98% | 102113-98-4 | MFCD08276279 | 321 42 | C24H19N
Chemscene 2-Iodo-5-trifluoromethylpyridine | 1g | CS-W004137 | 98% | 100366-75-4 | MFCD08741351 | 273 00 | C6H3F3IN
Chemscene | 2-Iodo-5-trifluoromethylpyridine | 1g | CS-W004137 | 98% | 100366-75-4 | MFCD08741351 | 273 00 | C6H3F3IN
Chemscene tert-Butyl 6-Oxo-2-azaspiro[3 3]heptane-2-carboxylate | 5g | CS-D0133 | 98% | 1181816-12-5 | MFCD15071430 | 211 26 | C11H17NO3
Chemscene | tert-Butyl 6-Oxo-2-azaspiro[3 3]heptane-2-carboxylate | 5g | CS-D0133 | 98% | 1181816-12-5 | MFCD15071430 | 211 26 | C11H17NO3
Chemscene Fmoc-D-Leu-OH | 5g | CS-W008021 | 98% | 114360-54-2 | MFCD00062957 | 353 42 | C21H23NO4
Chemscene | Fmoc-D-Leu-OH | 5g | CS-W008021 | 98% | 114360-54-2 | MFCD00062957 | 353 42 | C21H23NO4